問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
周銘霆
下載
2025-07-01 - 2030-12-31
Condition/Disease
Test Drug
Participate Sites23Sites
Recruiting23Sites
2024-02-01 - 2028-12-31
Participate Sites10Sites
Recruiting10Sites
2021-05-01 - 2025-12-31
Participate Sites14Sites
Recruiting12Sites
Terminated1Sites
2023-10-02 - 2030-09-30
2023-07-01 - 2026-01-31
Participate Sites7Sites
Recruiting7Sites
2024-05-01 - 2029-12-31
2025-09-30 - 2032-03-31
Participate Sites11Sites
Recruiting11Sites
2022-01-19 - 2027-10-20
Not yet recruiting2Sites
Recruiting5Sites
2023-04-01 - 2032-12-31
Participate Sites9Sites
Recruiting9Sites
2022-12-05 - 2024-09-30
Prevention of Ischemic Stroke 、Acute Non-cardioembolic Ischemic Stroke、 High-risk Transient Ischemic Attack
AsundexianPlacebo (for Asundexian)ApixabanPlacebo (for Apixaban)
Recruiting20Sites
全部
